A lawsuit was filed for certain investors in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares. Investors in NASDAQ: REGN shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
SAN DIEGO, CA / ACCESSWIRE / January 14, 2025 / The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shares.
Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and continue to hold any of those NASDAQ: REGN shares, should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
On January 07, 2025, a Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN investor filed a lawsuit against Regeneron Pharmaceuticals, Inc. over alleged securities laws violations. The plaintiff alleges that the defendants failed to disclose to investors that Regeneron paid credit card fees to distributors on the condition that distributors did not charge Eylea customers more to use a credit card, that these payments subsidized the prices that customers paid when using credit cards to purchase Eylea, that, as a result, Regeneron offered a price concession that lowered Eylea's selling price, that, because retina practices were sensitive to higher prices when using credit cards to purchase anti-VEGF medications, Regeneron's price concessions provided a competitive advantage, that, as a result of the foregoing, Regeneron misleadingly boosted reported Eylea sales, that, by failing to report its payment of credit card fees as price concessions, Regeneron overstated the ASP reported to federal agencies, thereby violating the False Claims Act, and that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) should contact the Shareholders Foundation, Inc.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.
Contact Information
View the original
press release on accesswire.com
